HomeTrading IdeasUS Dollar Steadies as...

US Dollar Steadies as Risk Appetite Eases on Data and Key Deadlines

  • Dollar tumbles 14% against the euro in the first half of the year
  • Spotlight stays on US budget bill and trade talks
  • US data deluge today, an appetizer for Thursday’s jobs report
  • Oil hovers around $66, gold rally gains momentum

New Month, Old Habits for the Dollar?

The is trying to start the new month on the front foot, following its recent underperformance. In June, the mighty greenback lost 4% against the , and around 2% versus both the and Antipodean currencies. These figures are even more striking on a year-to-date basis, with euro/dollar climbing 14% in the first half of 2025, cable rallying by 10%, and dropping by 8%.

The US President might view this dollar weakness as a significant boost for US exports. However, a growing number of market participants are voicing concerns that this move reflects deeper issues, as investors remain extremely skeptical about the short-term outlook, particularly regarding trade tensions and the US budget bill.

These unresolved issues and the continued dollar underperformance are casting a heavy shadow on the US stock market, despite the booming AI market. The and indices are up 5.5% and 7.9% this year, respectively, significantly underperforming the index that has climbed by 20% in 2025.

July Could Be a ‘Beautiful Month’

The countdown to both the unofficial July 4 and the much-advertised July 9 deadlines – for the budget bill and reciprocal tariffs, respectively – is underway. The Senate is still debating several amendments to the budget bill, but the Republicans are thought to be able to secure the 50 votes needed to approve this bill and send it back to the House for the final vote. Republicans also have a majority in the House, but there is discontent within their ranks.

Meanwhile, while US officials are advertising the progress made on the trade negotiations, deals remain elusive. Most countries are unwilling to accept tariffs hitting their critical industries – for example the Japanese PM appears adamant that car industry tariffs are simply not acceptable. Similarly, the EU appears ready to accept the 10% universal tariff, but it is seeking exemptions for a number of key sectors.

Notably, there seems to be a shift in the US administration’s trade strategy. Trump’s advisers are now targeting framework or baseline agreements instead of fully-fledged trade deals. In practice, this means that any trade agreements announced will not be final or complete, with discussions continuing during the summer – similar to the US-China trade developments. However, Trump will have the chance to advertise his success, despite their relative lack of substance.

Data Galore This Week

The Fed is preparing for this week’s busy data schedule. Both the and surveys will be published today, with the market paying extra attention to the employment and prices paid subcomponents of the latter, along with the May figure. It will be interesting to see how the dollar reacts to any potentially softer prints today.

While it could be a crucial week for Fed expectations, Fed members will probably have to keep one eye on Trump’s rhetoric. The personal attacks and name-calling against Fed Chair Powell continue, with the latest episode in this saga being that Trump reportedly sent a note to Powell asking him to lower rates.

The Fed Chair is attending the three-day ECB forum on central banking in Sintra, Portugal, where he will probably feel more at home compared to Washington, DC. Notably, he is scheduled to participate in a panel discussion at 13:30 GMT alongside BoE Governor Bailey, ECB President Lagarde, and BoJ Governor Ueda.Economic Calendar

Oil Is Range-bound, Gold Rallies

After substantial volatility in June, appear to have found a balance in the $66 area. This week’s data might beautify the oil demand picture, but investors will also have to take into account the continued output hikes by the OPEC+ alliance. There seems to be an effort by Saudi Arabia and its partners for a market share grab at the expense of lower revenue.

Finally, seems to be in a better mood today, climbing above a key trendline and easing fears of a protracted correction. The next two weeks, marked by a busy data calendar and various deadlines, might offer strong support for another upleg in gold.

Most Popular

More from Author

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength...

Read Now

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...

Dow Jones Forecast: Political Tensions and Tariff Risks Weigh on Outlook

US futures are rising on Monday after the extended holiday weekend. Uncertainty surrounding U.S. trade tariff policies are keeping investors cautious, whilst Tesla (NASDAQ:) is taking a hit after Musk announced plans to launch a political party.US Futures 0.78% at 44839 0.7% at 6266 0.53% at 23977In...

Why Is Apogee Therapeutics Stock Soaring On Monday? – Apogee Therapeutics (NASDAQ:APGE)

Apogee Therapeutics Inc. APGE stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday.This substantial increase in stock price follows the release of positive 16-week data from Part A of the Phase 2 APEX clinical trial of APG777, an anti-IL-13 antibody, for moderate-to-severe...

EUR/USD Slips as Trade Talks Stall and Retail Sales Disappoint

falls with trade talks in focus and following weak retail sales. Oil slips after OPEC+ increases output by more than expected.EUR/USD Falls With Trade Talks in Focus and After Weak Retail SalesThe EU and the US are nearing a framework agreement Eurozone retail sales fell -0.7% MoM EUR/USD...